Protein ENL
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 1–148 | Mutation:N111K | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6 | Resolution 2.64 Å R-free 0.230 |
| 2 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain B; UniProt 1–148 | Mutation:N111K | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6 | Resolution 2.64 Å R-free 0.230 |
| 3 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain C; UniProt 1–148 | Mutation:N111K | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6 | Resolution 2.64 Å R-free 0.230 |
| 4 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain D; UniProt 1–148 | Mutation:N111K | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6 | Resolution 2.64 Å R-free 0.230 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 7E7A | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 5J9S ENL YEATS in complex with histone H3 acetylation at K27 Deposited 2016-04-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
Fragment:UNP residues 1-148
|
Not recorded | SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.1M K/Na Tartrate, 0.1M Sodium citrate tribasic dihydrate, pH 5.6, 2M (NH4)2SO4
|
Resolution 2.70 Å R-free 0.210 |
| 6HPW Crystal structure of ENL (MLLT1) in complex with compound 20 Deposited 2018-09-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 8 GKT 3-iodanyl-4-methyl-~{N}-[2-(piperidin-1-ylmethyl)-3~{H}-benzimidazol-5-yl]benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;25% PEG 3350, 0.2M ammonium acetate, 0.1M bis-tris, pH 5.5
|
Resolution 1.90 Å R-free 0.281 |
| 6HPX Crystal structure of ENL (MLLT1) in complex with compound 19 Deposited 2018-09-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 4 GKQ ~{N}-[(3-chlorophenyl)methyl]-1-(2-pyrrolidin-1-ylethyl)benzimidazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;25% medium molecular weight PEG smears, 0.1M citrate, pH 5.5
|
Resolution 2.30 Å R-free 0.261 |
| 6HPY Crystal structure of ENL (MLLT1) in complex with compound 12 Deposited 2018-09-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 3 SO4 SULFATE ION × 1 GKN 3-[4-[(4-~{tert}-butylphenyl)carbonylamino]phenyl]propanoic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;25% PEG 3350, 0.2M ammonium sulfate, 0.1M bis-tris, pH 5.5
|
Resolution 2.00 Å R-free 0.260 |
| 6HPZ Crystal structure of ENL (MLLT1) in complex with acetyllysine Deposited 2018-09-22 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
Fragment:YEATS domain
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 ALY N(6)-ACETYLLYSINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;25% PEG 1500
|
Resolution 2.30 Å R-free 0.296 |
| 6HQ0 Crystal structure of ENL (MLLT1), apo form Deposited 2018-09-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;30% PEG 2000MME, 0.1M KBr
|
Resolution 1.81 Å R-free 0.237 |
| 6HT0 Crystal structure of MLLT1 (ENL) YEATS domain in complexed with compound 94 Deposited 2018-10-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | SO4 SULFATE ION × 1 EDO 1,2-ETHANEDIOL × 8 GQ8 1-cyclopropyl-~{N}-[2-[[(2~{S})-2-methylpyrrolidin-1-yl]methyl]-3~{H}-benzimidazol-5-yl]indazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;25% PEG3350, 0.2M ammonium sulfate, 0.1M bis-tris pH 5.5 or 25% PEG Smear Medi-um, 0.1M citrate pH 5.5
|
Resolution 1.80 Å R-free 0.230 |
| 6HT1 Crystal structure of MLLT1 (ENL) YEATS domain in complexed with SGC-iMLLT (compound 92) Deposited 2018-10-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | SO4 SULFATE ION × 2 EDO 1,2-ETHANEDIOL × 7 GQ5 1-methyl-~{N}-[2-[[(2~{S})-2-methylpyrrolidin-1-yl]methyl]-3~{H}-benzimidazol-5-yl]indazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;25% PEG3350, 0.2M ammonium sulfate, 0.1M bis-tris pH 5.5 or 25% PEG Smear Medi-um, 0.1M citrate pH 5.5
|
Resolution 2.10 Å R-free 0.252 |
| 6T1I Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 1 Deposited 2019-10-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | M7W 4-(4-ethanoylphenyl)-~{N}-[(6-methoxypyridin-3-yl)methyl]piperazine-1-carboxamide × 1 EDO 1,2-ETHANEDIOL × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;25% PEG 3350, 0.2 M sodium chloride, 0.1 M bis-tris pH 6.5
|
Resolution 1.80 Å R-free 0.232 |
| 6T1J Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 2 Deposited 2019-10-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 7 M7T ~{N}-[[4-(pyrrolidin-1-ylmethyl)phenyl]methyl]-4-thiophen-2-ylcarbonyl-piperazine-1-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;25% PEG 3350, 0.2M sodium chloride, 0.1M bis-tris pH 6.5
|
Resolution 1.97 Å R-free 0.275 |
| 6T1L Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 3 Deposited 2019-10-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 10 M7N ~{N}-[[4-(diethylaminomethyl)phenyl]methyl]-4-pyrimidin-2-yl-piperazine-1-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;25% PEG 3350, 0.2M sodium chloride, 0.1 M bis-tris pH 6.5
|
Resolution 2.00 Å R-free 0.265 |
| 6T1M Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 4 Deposited 2019-10-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | M8K 4-cyano-~{N}-[2-(piperidin-1-ylmethyl)-1~{H}-benzimidazol-5-yl]benzamide × 1 EDO 1,2-ETHANEDIOL × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;25% PEG 3350, 0.2M sodium chloride, 0.1M bis-tris pH 5.5
|
Resolution 1.85 Å R-free 0.275 |
| 6T1N Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 5 Deposited 2019-10-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | M7Z 4-chloranyl-~{N}-[2-(piperidin-1-ylmethyl)-3~{H}-benzimidazol-5-yl]benzamide × 1 EDO 1,2-ETHANEDIOL × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293.15 K;25% PEG 3350, 0.2M sodium chloride, 0.1M bis-tris pH 5.5
|
Resolution 1.95 Å R-free 0.266 |
| 6T1O Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 6 Deposited 2019-10-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | M82 4-iodanyl-~{N}-[2-(piperidin-1-ylmethyl)-3~{H}-benzimidazol-5-yl]benzamide × 1 EDO 1,2-ETHANEDIOL × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293.15 K;25% PEG 3350, 0.2M sodium chloride, 0.1M HEPES pH 7.5
|
Resolution 1.90 Å R-free 0.251 |
| 7B0T Crystal structure of MLLT1 YEATS domain T3 mutant in complex with benzimidazole-amide based compound 1 Deposited 2020-11-21 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomer |
Chain A
1–148(148 aa)
|
Not recorded | GKT 3-iodanyl-4-methyl-~{N}-[2-(piperidin-1-ylmethyl)-3~{H}-benzimidazol-5-yl]benzamide × 1 EDO 1,2-ETHANEDIOL × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;28% PEG 3350, 0.2M NaOAc, 0.1M Bis-Tris, pH6.0
|
Resolution 2.05 Å R-free 0.276 |
| 7B10 Crystal structure of MLLT1 YEATS domain T1 mutant in complex with benzimidazole-amide based compound 1 Deposited 2020-11-23 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomer |
Chain A
1–148(148 aa)
|
Not recorded | GKT 3-iodanyl-4-methyl-~{N}-[2-(piperidin-1-ylmethyl)-3~{H}-benzimidazol-5-yl]benzamide × 1 IOD IODIDE ION × 1 EDO 1,2-ETHANEDIOL × 11 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;25% w/v PEG 3350, 0.1M Bis-Tris, pH 5.5
|
Resolution 1.92 Å R-free 0.209 |
| 7E74 Crystal structure of ENL YEATS domain T3 mutant in complex with histone H3 acetylation at K27 Deposited 2021-02-25 | Different oligomeric state Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
|
Mutation:N111K | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6
|
Resolution 2.90 Å R-free 0.248 |
| 7E74 Crystal structure of ENL YEATS domain T3 mutant in complex with histone H3 acetylation at K27 Deposited 2021-02-25 | Different oligomeric state Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–148(148 aa)
|
Mutation:N111K | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6
|
Resolution 2.90 Å R-free 0.248 |
| 7E74 Crystal structure of ENL YEATS domain T3 mutant in complex with histone H3 acetylation at K27 Deposited 2021-02-25 | Different oligomeric state Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–148(148 aa)
|
Mutation:N111K | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6
|
Resolution 2.90 Å R-free 0.248 |
| 7E74 Crystal structure of ENL YEATS domain T3 mutant in complex with histone H3 acetylation at K27 Deposited 2021-02-25 | Different oligomeric state Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
1–148(148 aa)
|
Mutation:N111K | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;2M sodium formate, 0.1M sodium acetate trihydrate pH 4.6
|
Resolution 2.90 Å R-free 0.248 |
| 7E7C Crystal structure of ENL YEATS domain T1 mutant in complex with histone H3 acetylation at K27 Deposited 2021-02-25 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 IOD IODIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;291 K;25% PEG 4000, 0.1M MES pH 6.5, 0.2M Potassium iodide
|
Resolution 1.84 Å R-free 0.251 |
| 7X88 Crystal structure of ENL YEATS domain T2 mutant in complex with histone H3 acetylation at K27 Deposited 2022-03-11 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
|
Mutation:Deletion 112-113, V114L | CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;20% (w/v) PE G3350, 0.1M sodium citrate/citric acid pH 4.0, 0.2M sodium citrate tribasic
|
Resolution 2.25 Å R-free 0.240 |
| 7X8B Crystal structure of ENL T1 mutant YEATS domain in complex with histone H3 acetylation at K27 Deposited 2022-03-11 | Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;20 % (w/v) PEG 4000, 0.1M sodium citrate pH5.6, 20 % (v/v) 2-propanol
|
Resolution 2.30 Å R-free 0.226 |
| 7X8B Crystal structure of ENL T1 mutant YEATS domain in complex with histone H3 acetylation at K27 Deposited 2022-03-11 | Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–148(148 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;20 % (w/v) PEG 4000, 0.1M sodium citrate pH5.6, 20 % (v/v) 2-propanol
|
Resolution 2.30 Å R-free 0.226 |
| 7X8F Crystal structure of ENL T4 mutant YEATS domain in complex with histone H3 acetylation at K27 Deposited 2022-03-12 | Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
|
Mutation:insertions | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;20 % (w/v) PEG 4000, 0.1 M sodium citrate pH 5.6, 20 % (v/v) 2-propanol
|
Resolution 2.44 Å R-free 0.252 |
| 7X8F Crystal structure of ENL T4 mutant YEATS domain in complex with histone H3 acetylation at K27 Deposited 2022-03-12 | Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–148(148 aa)
|
Mutation:insertions | CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;20 % (w/v) PEG 4000, 0.1 M sodium citrate pH 5.6, 20 % (v/v) 2-propanol
|
Resolution 2.44 Å R-free 0.252 |
| 7X8G Crystal structure of ENL T1(H116P) mutant YEATS domain in complex with histone H3 acetylation at K27 Deposited 2022-03-12 | Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–148(148 aa)
|
Mutation:insertions | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;20 % (w/v) PEG 4000, 0.1M sodium citrate pH 5.6, 20 % (v/v) 2-propanol
|
Resolution 1.91 Å R-free 0.230 |
| 7X8G Crystal structure of ENL T1(H116P) mutant YEATS domain in complex with histone H3 acetylation at K27 Deposited 2022-03-12 | Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–148(148 aa)
|
Mutation:insertions | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;20 % (w/v) PEG 4000, 0.1M sodium citrate pH 5.6, 20 % (v/v) 2-propanol
|
Resolution 1.91 Å R-free 0.230 |
| 8PJI MLLT1 in complex with compound 10a Deposited 2023-06-23 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–148(148 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 DMS DIMETHYL SULFOXIDE × 1 ZJF ~{N}-cyclopentyl-1-(3-hydroxyphenyl)imidazole-4-carboxamide × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;100 mM Bis-Tris pH=7.0
150 mM AmSO4
Gradient 20-30% PEG3350
|
Resolution 1.70 Å R-free 0.277 |
| 9DUR Cryo-EM Structure of CRBN:dHTC1:ENL YEATS Deposited 2024-10-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–148(148 aa)
Fragment:YEATS domain
|
Not recorded | ZN ZINC ION × 1 A1IQT 2-[3-[2-[4-[[(5~{S})-1,3-bis(oxidanylidene)-2,7-diazaspiro[4.4]nonan-7-yl]sulfonylamino]piperidin-1-yl]ethylcarbamoyl]phenyl]-~{N}-cyclobutyl-imidazo[1,2-a]pyridine-6-carboxamide × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;30 mM HEPES/NaOH pH7.4, 150 mM NaCl. DMSO concentrations were kept below 2% (v/v)
cryo-EM vitrification conditions
Cryogen ETHANE;Grids were vitrified using a Leica EM GP plunge freezer operated at 90% humidity and 10 C. Grids were first pre-incubated with 4 uL of 10 uM CRBN-agnostic IKZF1_140-196_Q146A,G151N for 1 minute and then blotted from behind for 4 s. Immediately, 4 uL of mixturewas applied to the grids before blotting for 4 s and plunging into liquid ethane at -181 C
|
Resolution 2.90 Å |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 10 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain J
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 11 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain K
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 12 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain L
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 13 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain M
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 14 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain N
2–146(145 aa)
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 15 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain O
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 16 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain P
2–146(145 aa)
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
2–146(145 aa)
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
2–146(145 aa)
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 7 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain G
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
2–146(145 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
| 9EHI Crystal structure of ENL YEATS in complex with histone H3 methacrylated at K18 Deposited 2024-11-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 9 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain I
2–146(145 aa)
|
Not recorded | MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES monohydrate, pH 6.0, 20% (v/v) Jeffamine M600, pH 7.0
|
Resolution 2.60 Å R-free 0.267 |
25 other PDB entries and 46 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | ENL_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 4–149; UniProt 1–148 Author chain B; PDBConstruct 4–149; UniProt 1–148 Author chain C; PDBConstruct 4–149; UniProt 1–148 Author chain D; PDBConstruct 4–149; UniProt 1–148 |